🇺🇸 FDA
Patent

US 10913753

Thienopyridine carboxamides as ubiquitin-specific protease inhibitors

granted A61PA61P29/00A61P31/04

Quick answer

US patent 10913753 (Thienopyridine carboxamides as ubiquitin-specific protease inhibitors) held by Valo Early Discovery, Inc. expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Valo Early Discovery, Inc.
Grant date
Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P29/00, A61P31/04, A61P31/12, A61P35/00